⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Investors in Ultragenyx Pharmaceutical Inc. Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights – RARE
globenewswire.com
RARE
RARE FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE
globenewswire.com
RARE
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
RARE
Form 8-K
sec.gov
RARE
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy
globenewswire.com
RARE
RARE Stockholders Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
RARE
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
prnewswire.com
RARE
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
RARE
ULTRAGENYX DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE
accessnewswire.com
RARE